(Q38048511)

27 August 2017

title

Intestinal and multivisceral transplantation immunosuppression protocols--literature review (English)

1 reference

27 August 2017

1 reference

A P Trevizol

1

1 reference

27 August 2017

A I David

2

1 reference

27 August 2017

E R Dias

3

1 reference

27 August 2017

D Mantovani

4

1 reference

27 August 2017

R Pécora

5

1 reference

27 August 2017

L A C D'Albuquerque

6

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

Transplantation Proceedings

27 August 2017

published in

1 reference

27 August 2017

volume

44

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

2445-2448

1 reference

Small bowel transplantation

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Transplantation of multiple abdominal viscera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

FK 506 for liver, kidney, and pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Clinical intestinal transplantation: a decade of experience at a single center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

2003 report of the intestine transplant registry: a new era has dawned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Presensitization: the problem and its management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Infectious complications after multivisceral transplantation in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

Proposed protocol to reduce bacterial infectious complications in living related small bowel transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.016

10.1016/J.TRANSPROCEED.2012.07.016

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference